An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism

被引：0
|
作者：
Eberhard Nieschlag
Pierre-Marc G. Bouloux
Barbara J. Stegmann
R. Ravi Shankar
Yanfen Guan
Anjela Tzontcheva
Christine McCrary Sisk
Hermann M. Behre
机构：
[1] University Hospital of Muenster,
[2] Center of Reproductive Medicine and Andrology,undefined
[3] The Royal Free Hospital,undefined
[4] Merck & Co.,undefined
[5] Inc.,undefined
[6] University Hospital Halle (Saale),undefined
[7] Martin Luther University Halle-Wittenberg,undefined
来源：
Reproductive Biology and Endocrinology | / 15卷
关键词：
Corifollitropin alfa; Gonadotropin deficiency; Hypogonadotropic hypogonadism; Male infertility; Testis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A Single-center, Open-label, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of the Indirect Bonding Technique
    Murakami, Takashi
    Kawanabe, Noriaki
    Kataoka, Tomoki
    Hoshijima, Mitsuhiro
    Komori, Hiroki
    Fujisawa, Atsuro
    Kamioka, Hiroshi
    ACTA MEDICA OKAYAMA, 2016, 70 (05) : 413 - 416
  • [42] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
    Pavel, Marianne
    Benavent, Marta
    Perros, Petros
    Srirajaskanthan, Raj
    Warner, Richard R. P.
    Kulke, Matthew H.
    Anthony, Lowell B.
    Kunz, Pamela L.
    Hoersch, Dieter
    Lapuerta, Pablo
    Fleming, Rosanna
    Gross, David J.
    PANCREAS, 2018, 47 (03) : 350 - 350
  • [43] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
    Pavel, M.
    Benavent, M.
    Perros, P.
    Srirajaskanthan, R.
    Warner, R. R. P.
    Kulke, M. H.
    Anthony, L. B.
    Kunz, P.
    Hoersch, D.
    Lapuerta, P.
    Fleming, R.
    Gross, D.
    NEUROENDOCRINOLOGY, 2017, 105 : 205 - 205
  • [44] Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial
    Huang, Xiao
    Li, Chao
    Li, Wei-hui
    Luo, Yan-li
    Wang, Biao
    Zhang, Wei
    Gan, Jian-jun
    Ji, Jian-lin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (06) : 594 - 599
  • [45] Evaluation of efficacy and safety of Lascufloxacin tablet for Nursing and healthcareassociated pneumonia: Single-arm, open-label clinical trial
    Hosogaya, Naoki
    Takazono, Takahiro
    Ota, Kenji
    Ito, Yuta
    Ashizawa, Nobuyuki
    Takeda, Kazuaki
    Iwanaga, Naoki
    Yoshino, Yukari
    Ishikawa, Yasuyuki
    Izumikawa, Koichi
    Yatera, Kazuhiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    RESPIROLOGY, 2023, 28 : 204 - 205
  • [46] The efficacy and safety of ciclosporin (Equoral®) capsules after renal transplantation: A muiticentre, open-label, phase IV clinical trial
    Durlik, Magdalena
    Paczek, Leszek
    Rutkowski, Boleslaw
    Lewandowska, Dorota
    Debska-Slizien, Alicja
    Chamienia, Andrzej
    Wyzgal, Janusz
    Ognista-Gajda, Anna
    Niemczyk, Mariusz
    ANNALS OF TRANSPLANTATION, 2010, 15 (03) : 51 - 59
  • [47] Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial
    Rafalsky, Vladimir
    Averyanov, Alexander
    Bart, Boris
    Minina, Elena
    Putilovskiy, Mikhail
    Andrianova, Elena
    Epstein, Oleg
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 47 - 55
  • [48] Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
    Liu, Jieqiong
    Liu, Qiang
    Li, Ying
    Li, Qian
    Su, Fengxi
    Yao, Herui
    Su, Shicheng
    Wang, Quanren
    Jin, Liang
    Wang, Ying
    Lau, Wan Yee
    Jiang, Zefei
    Song, Erwei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [49] Efficacy and safety of oral levofloxacin in adult respiratory tract infections:: A multicenter, open-label study
    Hermida, EC
    Flores, GR
    Zavala, TI
    Arechavaleta, SJ
    Cruz, PE
    Muñoz, BF
    Aparicio, CA
    ADVANCES IN THERAPY, 1999, 16 (01) : 22 - 28
  • [50] ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL
    Gopaluni, Seerapani
    Goymer, Donna
    McClure, Mark
    Cahill, Hugh
    Broadhurst, Elizabeth
    Smith, Rona
    Jayne, David
    RHEUMATOLOGY, 2019, 58
12345